Colorectal Cancer

Scandion Oncology ready for phase II with SCO-101

Scandion Oncology's candidate SCO-101 is being developed to fight resistance to cancer drugs and is ready to enter phase...

Commercial opportunities with 2cureX new agreements

2cureX aims to introduce its cancer test...

2cureX tops off eventful first half of 2019 with addition of expert clinician as Chief Medical Officer

2019 has seen 2cureX reaping the benefits of...

2cureX enrolls first patients in pancreatic cancer clinical trials

The burden of pancreatic cancer is on the...

2cureX restructures the board and prepares a financing round of SEK 25 million

Danish 2cureX today announced both board changes and a...